Average and maximum levels of COHb during ECMO before VAP significantly predicted VAP onset after adjusting for clinically meaningful confounders (BMI, the year of admission, transferrin before ECMO, COHb before ECMO, and respiratory system compliance) (Table 3A). This evidence concerns the gene TF and ventilator-associated pneumonia.